Researchers and doctors from UCLA Health will present 23 studies covering lung cancer, pediatric cancer, survivorship, and healthcare equity,...
Vous n'êtes pas connecté
AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation to import Durvalumab for sale and distribution. The drug, combined with chemotherapy, treats resectable non-small cell lung cancer without specific genetic mutations. Lung cancer remains a significant cause of mortality in India, highlighting the importance of this development.
Researchers and doctors from UCLA Health will present 23 studies covering lung cancer, pediatric cancer, survivorship, and healthcare equity,...
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the...
DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight, 2024,” report provides comprehensive insights about...
THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer...
The FDA approves AstraZeneca's Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.
WEDNESDAY, Sept. 18, 2024 -- Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b...
Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...
Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...
Researchers from the Harry Perkins Institute and the University of Western Australia have discovered that honeybee venom can kill cancer cells. The...
Shanghai Henlius Biotech, Inc., a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the...